However, the importance of splicing modulation after PRMT5 inhibition is suggested by the fact that PRMT5 inhibitors kill more efficiently SRSF2P95H-mutated cells than SRSF2WT control cells in a model of acute leukemia due to MLL-AF9 gene fusion [139]. This evidence concerns the gene PRMT5 and acute leukemia.